Print

Guangxi CDC DNA vaccine

A randomized, placebo-controlled, double-blind trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine(EnvDNA)

Trial Details:

I Completed
Changchun BCHD, Guangxi CDC March 01, 2005
Chinese DNA
Chinese DNA DNA
China 49